189 related articles for article (PubMed ID: 25194782)
1. The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder.
Sylvia LG; Rabideau DJ; Nierenberg AA; Bowden CL; Friedman ES; Iosifescu DV; Thase ME; Ketter T; Greiter EA; Calabrese JR; Leon AC; Ostacher MJ; Reilly-Harrington N
J Affect Disord; 2014 Dec; 169():144-8. PubMed ID: 25194782
[TBL] [Abstract][Full Text] [Related]
2. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
Nierenberg AA; Friedman ES; Bowden CL; Sylvia LG; Thase ME; Ketter T; Ostacher MJ; Leon AC; Reilly-Harrington N; Iosifescu DV; Pencina M; Severe JB; Calabrese JR
Am J Psychiatry; 2013 Jan; 170(1):102-10. PubMed ID: 23288387
[TBL] [Abstract][Full Text] [Related]
3. Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.
Deckersbach T; Nierenberg AA; McInnis MG; Salcedo S; Bernstein EE; Kemp DE; Shelton RC; McElroy SL; Sylvia LG; Kocsis JH; Bobo WV; Friedman ES; Singh V; Tohen M; Bowden CL; Ketter TA; Calabrese JR; Thase ME; Reilly-Harrington NA; Rabideau DJ; Kinrys G; Kamali M
J Clin Psychiatry; 2016 Jan; 77(1):100-8. PubMed ID: 26845265
[TBL] [Abstract][Full Text] [Related]
4. Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
Nierenberg AA; Sylvia LG; Leon AC; Reilly-Harrington NA; Ketter TA; Calabrese JR; Thase ME; Bowden CL; Friedman ES; Ostacher MJ; Novak L; Iosifescu DV;
Clin Trials; 2009 Dec; 6(6):637-48. PubMed ID: 19933719
[TBL] [Abstract][Full Text] [Related]
5. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
6. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.
Miklowitz DJ; Otto MW; Frank E; Reilly-Harrington NA; Kogan JN; Sachs GS; Thase ME; Calabrese JR; Marangell LB; Ostacher MJ; Patel J; Thomas MR; Araga M; Gonzalez JM; Wisniewski SR
Am J Psychiatry; 2007 Sep; 164(9):1340-7. PubMed ID: 17728418
[TBL] [Abstract][Full Text] [Related]
7. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.
Nierenberg AA; McElroy SL; Friedman ES; Ketter TA; Shelton RC; Deckersbach T; McInnis MG; Bowden CL; Tohen M; Kocsis JH; Calabrese JR; Kinrys G; Bobo WV; Singh V; Kamali M; Kemp D; Brody B; Reilly-Harrington NA; Sylvia LG; Shesler LW; Bernstein EE; Schoenfeld D; Rabideau DJ; Leon AC; Faraone S; Thase ME
J Clin Psychiatry; 2016 Jan; 77(1):90-9. PubMed ID: 26845264
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.
Nierenberg AA; Sylvia LG; Leon AC; Reilly-Harrington NA; Shesler LW; McElroy SL; Friedman ES; Thase ME; Shelton RC; Bowden CL; Tohen M; Singh V; Deckersbach T; Ketter TA; Kocsis JH; McInnis MG; Schoenfeld D; Bobo WV; Calabrese JR;
Clin Trials; 2014 Feb; 11(1):114-27. PubMed ID: 24346608
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
[TBL] [Abstract][Full Text] [Related]
10. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
Kim SJ; Lee YJ; Lee YJ; Cho SJ
J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
[TBL] [Abstract][Full Text] [Related]
11. Psychotherapy use in bipolar disorder: Association with functioning and illness severity.
Sylvia LG; Thase ME; Reilly-Harrington NA; Salcedo S; Brody B; Kinrys G; Kemp D; Shelton RC; McElroy SL; Kocsis JH; Bobo WV; Kamali M; McInnis M; Friedman E; Tohen M; Bowden CL; Ketter TA; Singh V; Calabrese J; Nierenberg AA; Rabideau DJ; Elson CM; Deckersbach T
Aust N Z J Psychiatry; 2015 May; 49(5):453-61. PubMed ID: 25680360
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes associated with comorbid posttraumatic stress disorder among patients with bipolar disorder.
Passos IC; Jansen K; Cardoso Tde A; Colpo GD; Zeni CP; Quevedo J; Kauer-Sant'Anna M; Zunta-Soares G; Soares JC; Kapczinski F
J Clin Psychiatry; 2016 May; 77(5):e555-60. PubMed ID: 27135375
[TBL] [Abstract][Full Text] [Related]
13. Poor quality of life and functioning in bipolar disorder.
Sylvia LG; Montana RE; Deckersbach T; Thase ME; Tohen M; Reilly-Harrington N; McInnis MG; Kocsis JH; Bowden C; Calabrese J; Gao K; Ketter T; Shelton RC; McElroy SL; Friedman ES; Rabideau DJ; Nierenberg AA
Int J Bipolar Disord; 2017 Dec; 5(1):10. PubMed ID: 28188565
[TBL] [Abstract][Full Text] [Related]
14. Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder.
Wrobel AL; Köhler-Forsberg O; Sylvia LG; Russell SE; Dean OM; Cotton SM; Thase M; Calabrese JR; Deckersbach T; Tohen M; Bowden CL; McInnis MG; Kocsis JH; Friedman ES; Ketter TA; Shelton RC; Ostacher MJ; Iosifescu DV; Berk M; Turner A; Nierenberg AA
Acta Psychiatr Scand; 2022 Jun; 145(6):615-627. PubMed ID: 35243620
[TBL] [Abstract][Full Text] [Related]
15. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
Sylvia LG; Shelton RC; Kemp DE; Bernstein EE; Friedman ES; Brody BD; McElroy SL; Singh V; Tohen M; Bowden CL; Ketter TA; Deckersbach T; Thase ME; Reilly-Harrington NA; Nierenberg AA; Rabideau DJ; Kinrys G; Kocsis JH; Bobo WV; Kamali M; McInnis MG; Calabrese JR
Bipolar Disord; 2015 Mar; 17(2):212-23. PubMed ID: 25130321
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
17. Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder.
Sylvia LG; Friedman ES; Kocsis JH; Bernstein EE; Brody BD; Kinrys G; Kemp DE; Shelton RC; McElroy SL; Bobo WV; Kamali M; McInnis MG; Tohen M; Bowden CL; Ketter TA; Deckersbach T; Calabrese JR; Thase ME; Reilly-Harrington NA; Singh V; Rabideau DJ; Nierenberg AA
J Affect Disord; 2013 Nov; 151(2):722-727. PubMed ID: 23993440
[TBL] [Abstract][Full Text] [Related]
18. Sexual Dysfunction and Mood Stabilizers in Long-Term Stable Patients With Bipolar Disorder.
García-Blanco A; García-Portilla MP; Fuente-Tomás L; Batalla M; Sánchez-Autet M; Arranz B; Safont G; Arqués S; Livianos L; Sierra P
J Sex Med; 2020 May; 17(5):930-940. PubMed ID: 32139195
[TBL] [Abstract][Full Text] [Related]
19. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
20. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
Goldberg JF; Harrow M
J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
